Simulations Plus (NASDAQ:SLP) Earns Neutral Rating from BTIG Research

Simulations Plus (NASDAQ:SLP)‘s stock had its “neutral” rating reiterated by BTIG Research in a report issued on Wednesday, Benzinga reports.

A number of other research analysts have also weighed in on the stock. Weiss Ratings raised shares of Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a research note on Friday, July 10th. William Blair downgraded Simulations Plus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 17th. Craig Hallum downgraded shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 target price for the company. in a research report on Thursday, June 18th. Finally, Wall Street Zen lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. Seven investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $17.25.

Simulations Plus Price Performance

NASDAQ SLP opened at $18.50 on Wednesday. The stock has a market capitalization of $374.16 million, a P/E ratio of 46.25 and a beta of 1.31. The business has a 50 day simple moving average of $18.41 and a 200 day simple moving average of $16.71. Simulations Plus has a one year low of $11.09 and a one year high of $21.01.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Thursday, July 9th. The technology company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.07. Simulations Plus had a net margin of 9.88% and a return on equity of 13.50%. The firm had revenue of $21.89 million during the quarter, compared to the consensus estimate of $20.90 million.

Institutional Investors Weigh In On Simulations Plus

A number of hedge funds have recently made changes to their positions in SLP. First Light Asset Management LLC lifted its holdings in Simulations Plus by 6.1% in the 2nd quarter. First Light Asset Management LLC now owns 2,792,677 shares of the technology company’s stock worth $51,134,000 after buying an additional 159,854 shares during the period. Meros Investment Management LP purchased a new position in shares of Simulations Plus during the second quarter valued at approximately $2,384,493. Polar Asset Management Partners Inc. bought a new position in shares of Simulations Plus during the second quarter valued at approximately $2,341,000. Groupe la Francaise purchased a new stake in Simulations Plus in the second quarter worth $2,329,000. Finally, Renaissance Technologies LLC lifted its stake in Simulations Plus by 807.5% in the first quarter. Renaissance Technologies LLC now owns 181,500 shares of the technology company’s stock worth $2,145,000 after acquiring an additional 161,500 shares during the period. 78.08% of the stock is currently owned by institutional investors.

About Simulations Plus

Simulations Plus, Inc develops software and provides services that support pharmaceutical research, drug development and regulatory decision-making. Its technologies help scientists model how drug compounds behave in the body, assess formulation and delivery characteristics, and evaluate potential safety and efficacy outcomes.

The company’s software portfolio includes GastroPlus, a platform for physiologically based pharmacokinetic and pharmacodynamic modeling; ADMET Predictor, which forecasts absorption, distribution, metabolism, excretion and toxicity properties; and DDDPlus, which simulates drug dissolution and dosage-form performance.